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NRF2 regulates the glutamine 
transporter Slc38a3 (SNAT3) in 
kidney in response to metabolic 
acidosis
Adam Lister1,3, Soline Bourgeois2,3, Pedro H. Imenez Silva  2,3, Isabel Rubio-Aliaga2,3, 
Philippe Marbet1,3, Joanne Walsh4, Luke M. Shelton4, Bettina Keller2, Francois Verrey2,3, 
Olivier Devuyst2,3, Pieter Giesbertz  5, Hannelore Daniel5, Christopher E. Goldring4,  
Ian M. Copple4, Carsten A. Wagner  2,3 & Alex Odermatt  1,3
Expression of the glutamine transporter SNAT3 increases in kidney during metabolic acidosis, 
suggesting a role during ammoniagenesis. Microarray analysis of Nrf2 knock-out (KO) mouse kidney 
identified Snat3 as the most significantly down-regulated transcript compared to wild-type (WT). 
We hypothesized that in the absence of NRF2 the kidney would be unable to induce SNAT3 under 
conditions of metabolic acidosis and therefore reduce the availability of glutamine for ammoniagenesis. 
Metabolic acidosis was induced for 7 days in WT and Nrf2 KO mice. Nrf2 KO mice failed to induce Snat3 
mRNA and protein expression during metabolic acidosis. However, there were no differences in blood 
pH, bicarbonate, pCO2, chloride and calcium or urinary pH, ammonium and phosphate levels. Normal 
induction of ammoniagenic enzymes was observed whereas several amino acid transporters showed 
differential regulation. Moreover, Nrf2 KO mice during acidosis showed increased expression of renal 
markers of oxidative stress and injury and NRF2 activity was increased during metabolic acidosis in 
WT kidney. We conclude that NRF2 is required to adapt the levels of SNAT3 in response to metabolic 
acidosis. In the absence of NRF2 and SNAT3, the kidney does not have any major acid handling defect; 
however, increased oxidative stress and renal injury may occur.
The kidney plays a major role in maintaining pH homeostasis and protecting against systemic pH disruption 
by excreting acids, reclaiming filtered bicarbonate (HCO3−) and by de novo synthesis of HCO3− to compen-
sate for HCO3− used by metabolism1. HCO3− synthesis in the proximal tubule is mainly generated by ammo-
niagenesis, in a process that also facilitates the excretion of protons from the proximal tubule in the form of 
ammonium (NH4+)1. In the collecting duct, excreted ammonia (NH3) acts as urinary buffer for secreted pro-
tons in the filtrate, which allows for further proton excretion by vacuolar H+-ATPases1–4. Ammoniagenesis is 
a multistep, enzymatically driven process utilizing the amino acid glutamine to yield two molecules of NH3 
and two molecules of HCO3− 5. Metabolic acidosis stimulates renal metabolism of glutamine, while concomi-
tantly the level of glutamine in the blood decreases5,6. Specifically, glutamine is converted to glutamate, a pro-
cess facilitated by phosphate-dependent glutaminase (GLS) to yield one molecule of NH4+. Glutamate is further 
converted to α-ketoglutarate by glutamate dehydrogenase (GDH) producing an additional NH3 molecule. The 
α-ketoglutarate is eventually directed into the tricarboxylic acid (TCA) cycle, yielding one molecule of HCO3−, 
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and the oxaloacetate derivate is directed into the gluconeogenic pathway, a process facilitated by cytosolic phos-
phoenolpyruvate carboxykinase (PEPCK), which yields the final molecule of HCO3− 5.
Under metabolic acidosis net extraction of glutamine from the plasma reaches 35%, a number that is beyond 
what is normally filtered by the kidney, suggesting that basolateral glutamine influx transporters contribute sub-
stantially to cellular glutamine supply5. Indeed, it has been suggested that during acute acidosis the direction in 
which the basolateral glutamine exchange transporter LAT2–4F2hc directs glutamine flux may be to favor intra-
cellular import5,7. During chronic metabolic acidosis, the expression of the glutamine transporter Snat3 (Slc38a3) 
is induced in parallel with other pH sensitive genes involved in glutamine metabolism, i.e. Gls and Pepck8–13. In 
Snat3 knock-out (KO) mice, urinary NH4+ excretion was reduced, further supporting its potential role in renal 
ammoniagenesis7,14.
The transcription factor nuclear factor erythroid 2-related factor 2 (NRF2) regulates the basal and inducible 
expression of a battery of cell defense genes and serves as a mechanism for cells to resist chemical and oxidative 
stress15,16. Under baseline conditions, the Kelch-like ECH-associated protein 1 (KEAP1) targets NRF2 for ubiqui-
tylation and subsequent proteasomal degradation17. In response to cellular stress, the interaction between NRF2 
and KEAP1 is disrupted, resulting in the nuclear accumulation of de novo synthesized NRF2, where it binds and 
activates antioxidant response elements (AREs) in the promoter regions of target genes, such as NAD(P)H dehy-
drogenase quinone 1 (NQO1) and Glutamate-Cysteine Ligase Catalytic Subunit (GCLC)16,18. More recently, addi-
tional mechanisms for controlling the activity of NRF2 have been described, which include alternative interacting 
partners, transcriptional upregulation by a plethora of transcription factors which bind to specific sites within 
the Nrf2 promoter, and post-translational modifications19. Apart from regulation of cell defense, it has become 
apparent that NRF2 can influence intermediary metabolism and mitochondrial function19,20. With respect to glu-
tamine metabolism, when NRF2 is constitutively activated, glutamine is preferentially ushered into glutathione 
synthesis and the TCA cycle21.
Recently, microarray and RT-PCR analyses of kidneys from Nrf2 KO mice identified Snat3 as the most signifi-
cantly down-regulated transcript compared to wild-type (WT) kidney22. Since SNAT3 is suggested to play a major 
role in the supply of glutamine during chronic metabolic acidosis, we investigated under conditions of metabolic 
acidosis and in the absence of NRF2 whether SNAT3 is induced in the kidney in order to maintain an adequate 
supply of glutamine for ammoniagenesis.
Results
NRF2 regulates SNAT3 in the kidney upon metabolic acidosis. In agreement with our previous 
work22, we confirmed that kidneys from Nrf2 KO mice express depleted levels of Snat3 mRNA and significantly 
lower protein compared to WT kidneys (Fig. 1a,b and Supplemental Fig. S1). However, deletion of Nrf2 did not 
affect Snat3 mRNA levels in liver and brain, suggesting that the Nrf2-dependent regulation was kidney-specific 
(Fig. 1c,d). Interestingly, Nrf2 KO mice showed a trend to induce SNAT3 mRNA; however, they were unable to 
induce SNAT3 significantly in the kidney upon metabolic acidosis (Fig. 1a,b). Under baseline homeostatic con-
ditions, SNAT3 is mostly expressed in the basolateral membrane of the S3 segment of the proximal tubule and 
extends to the S2 segment during metabolic acidosis11–13. To determine whether NRF2 is required for SNAT3 
induction in the proximal tubule upon acid loading and if primary proximal convoluted tubular cells (PCT) 
could be utilized as a model to investigate the biological mechanisms of action of the SNAT3 transporter, we 
depleted Nrf2 in PCT with targeted siRNA molecules and exposed the cells to acidic media at pH 6.5 or control 
media at pH 7.4. siRNA depletion of Nrf2 caused a decrease in the mRNA and protein expression levels of Nrf2 
and of mRNA levels of the NRF2 target genes Nqo1, Gstm1, Gsta3, Gclc and Gclm at both pH 7.4 and pH 6.5 
(Supplemental Fig. S2). PCT transfected with scrambled control siRNA showed a significant increase in Snat3 
mRNA expression following exposure to acidic media; whereas depletion of Nrf2 abrogated the induction of 
Snat3 mRNA at pH 6.5 (Fig. 1e). However, unlike the in vivo study, we did not detect any SNAT3 protein expres-
sion under any of the conditions tested and therefore cannot utilize this model for further mechanistic testing 
(Supplemental Fig. S2). Also, although no morphological changes were observed upon incubating cells at lower 
pH, we cannot fully exclude the contribution of toxicity at the non-physiological pH of 6.5.
Nrf2 KO mice do not exhibit any major acid handling defects. Since SNAT3 has been considered 
a critical transporter in the proximal tubule to supply glutamine for ammoniagenesis, we next tested blood and 
urine acid-base parameters in WT and Nrf2 KO mice under baseline conditions and after a dietary acid-loading. 
At baseline, Nrf2 KO mice exhibited no major defect in acid handling compared to WT mice. However, plasma 
pH and bicarbonate showed a trend to be lower while plasma chloride tended to be elevated in Nrf2 KO mice 
compared to WT (Table 1). Urinary pH was significantly more acidic in Nrf2 KO mice with higher urinary 
ammonium as well as phosphate, titratable acidity and net acid excretion compared to the control group (Table 2, 
Supplementary Table S1). During the acute acid load, Nrf2 KO mice were able to decrease their urinary pH and 
increased their urinary ammonium and phosphate excretion as much as the control mice (Table 2). Finally, after 7 
days of dietary HCl load, blood pH, bicarbonate and pCO2 remained lower than under control diet in both groups 
of mice while blood chloride was increased (Table 1). Meanwhile, Nrf2 KO mice could still acidify their urinary 
pH and significantly increased their urinary ammonium and net acid excretions as much as WT mice (Table 2). 
Phosphate as well as titratable acid excretions were lower than at baseline after 7 days HCl load in both genotypes; 
however, Nrf2 KO mice excreted more phosphate and titratable acids than WT mice when normalized for cre-
atinine. However, when normalized for 24 h urine volume, the difference for titratable acids and phosphate dis-
appeared (Supplementary Table S1). Since urine volumes were small, sampling may not have been complete and 
quantitative in all animals. On the other hand, normalization to creatinine may also induce a bias as creatinine is 
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actively secreted into urine and the role of Nrf2 in this process unknown. Nevertheless, the reduction in SNAT3 
induction during metabolic acidosis in Nrf2 KO mice was not associated with a failure to adapt to an acid-load.
NRF2 does not affect the expression of ammoniagenic and gluconeogenic enzymes induced 
by metabolic acidosis. In addition to SNAT3, the mRNA of enzymes involved in ammoniagenesis and 
Figure 1. NRF2 regulates basal and metabolic acidosis induced SNAT3 levels in the kidney. WT and Nrf2 KO 
mice were fed a normal diet or a HCl containing diet for 7 days. (a) qPCR analysis of Snat3 mRNA expression 
in the kidney. Snat3 mRNA levels were normalized to Ppia. (b) Immunoblot detection of SNAT3 using 20 µg 
total kidney membrane preparation. β-TUBULIN was used as a house-keeping control. (c,d) qPCR analysis 
of Snat3 mRNA expression in liver and brain. (e) Primary proximal convoluted tubular cells (PCT) from WT 
kidneys were isolated, followed by depletion of Nrf2 with targeted siRNA molecules and exposure of the cells to 
normal or acidic media (pH 7.4 or 6.5) for 24 h. qPCR analysis of Snat3 mRNA expression in primary PCT. Data 
represent mean ± S.D. of n = 4–6 animals per group (a–d) or n = 4 independent PCT preparations (e). Statistical 
analysis for qPCR was performed with a one-way analysis of variance (with Tukey’s post test); ***P ≤ 0.001; 
****P ≤ 0.0001. Statistical analysis for immunoblotting was performed with Student’s t-test; a = 0.05.
Baseline 7 days HCl
WT
N = 6
Nrf2 KO
N = 6
WT
N = 6
Nrf2 KO
N = 6
pH 7.34 ± 0.01 7.29 ± 0.07 7.22 ± 0.08## 7.18 ± 0.12##
pCO2 (mmHg) 47.7 ± 2.8 46.1 ± 1.0 40.6 ± 3.3## 42.1 ± 3.5##
HCO3− (mM) 24.9 ± 1.8 21.72 ± 3.36 15.92 ± 2.27## 15.28 ± 3.28##
pO2 (mmHg) 57.8 ± 6.7 61.3 ± 8.6 58.7 ± 1.9 62.9 ± 1.7
Na+ (mM) 155.2 ± 7.8 153.3 ± 2.0 153.7 ± 1.5 154.3 ± 2.4
Cl− (mM) 116.2 ± 0.7 118.7 ± 2.6 123.3 ± 2.2### 123.5 ± 3.8###
Ca2+ (mM) 1.29 ± 0.03 1.32 ± 0.02 1.40 ± 0.05# 1.40 ± 0.07#
Table 1. Blood values in C57Bl6 and Nrf2 KO mice under normal diet and during a 7 days acid load Summary 
of blood data obtained from WT and Nrf2 KO mice fed a normal diet (control) or a HCl-containing standard 
diet for 7 days (acid). Data represent mean ± S.D. of n = 6 animals per group. Statistical analysis was performed 
with a one-way analysis of variance (with Tukey’s post test); *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001 for differences 
between genotypes for the same treatment and #P ≤ 0.05; ##P ≤ 0.01; ###P ≤ 0.001 for differences between 
untreated and treated mice for the same genotype.
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subsequent gluconeogenesis, GLS and PEPCK, respectively, were also up-regulated in response to metabolic aci-
dosis (Fig. 2a–d). However, no differences were observed in mRNA and protein expression of Gls and Pepck in 
Nrf2 KO mice upon metabolic acidosis compared to WT control (Fig. 2a–d).
Nrf2 KO mice exhibit altered amino acid profiles and amino acid transporter expression upon 
metabolic acidosis. Although we found that NRF2 was indispensable for SNAT3 induction upon metabolic 
acidosis both in vivo and in vitro, we did not observe any major defect in ammonium excretion in the kidney. 
Since SNAT3 has been postulated to be the major upregulated basolateral glutamine transporter in the kidney 
during chronic metabolic acidosis, we explored possible mechanisms underlying the ability of the kidney to 
compensate for its loss in Nrf2 KO mice. We first checked for differences in the amino acid profile in plasma and 
kidney of Nrf2 KO compared to WT upon metabolic acidosis. The profile in plasma and kidney of Nrf2 KO mice 
differed for several amino acids from WT mice (Supplementary Tables S2 and S3). From the 30 amino acids and 
derivatives measured in plasma glutamine, glutamate, histidine, phenylalanine, 3-methylhistidine and GABA 
were significantly increased in the Nrf2 KO mice when compared to WT mice. Glutamine and histidine are 
substrates of SNAT3, and glutamate and GABA are involved in glutamine metabolism, which could explain the 
altered profile observed in the plasma of Nrf2 KO mice. In kidney, from the 33 amino acids and derivatives meas-
ured histidine, glycine and beta-alanine were decreased and phenylalanine, valine, anserine and carnosine were 
significantly increased in the Nrf2 KO mice when compared to WT mice. No changes between genotypes could 
be observed in the glutamine, glutamate and GABA concentrations.
Next, we examined a panel of genes encoding transporters which handle glutamine and other amino acids that 
can fuel ammoniagenesis (Snat 1,2,4, and 7 (Slc38a1,2,4, and 7), b0,+at (Slc7a9), y+Lat1 (Slc7a7), 4F2hc (Slc3a2), 
Tat1 (Slc16a10), Lat2 (Slc7a8), and B0at1 (Slc6a19)), transport ammonium (Rhcg, Nkcc2, Nhe4), protons (Nhe3) 
(Slc9a3 and 4), and calcium (Ncx1, Trpv5, Calb1 and Pmca4). Snat1 mRNA was significantly upregulated in Nrf2 
KO kidney upon metabolic acidosis (Fig. 3a). None of the other members of the Snat (Slc38) family tested were 
upregulated at mRNA level by metabolic acidosis (Fig. 3b–d). The mRNA expression of the amino acid trans-
porters b0,+at and y+lat1 were significantly suppressed upon metabolic acidosis in WT kidney, in agreement with 
our previous work12, whereas the expression remained unchanged in Nrf2 KO kidneys (Supplementary Fig. S3). 
The same pattern was observed for 4F2hc (Fig. 4a). No change in mRNA expression was observed for Lat2, Tat1, 
and B0at1. (Fig. 4c,e,g). At protein level, no difference was observed between WT and Nrf2 KO at baseline and 
in acid loaded conditions for 4F2hc, LAT2, TAT1 and B0AT1 (Fig. 4b,d,f,h). Additionally, no change in mRNA 
levels was observed for the ammonia transporter (Rhcg), the ion and ammonium transporter Nkcc2, and the 
Na+/H+ exchanger Nhe3 (Supplementary Fig. S3). However, the mRNA levels of the Na+/H+ exchanger Nhe4 
were significantly up-regulated in kidneys from Nrf2 KO mice under metabolic acidosis (Supplementary Fig. S3). 
Furthermore, no change was observed in the mRNA expression of proteins involved in active renal calcium han-
dling, namely Ncx1, Trpv5, Calb1, and Pmca4A (Supplementary Fig. S4).
Metabolic acidosis induces NRF2 activity in WT kidney. In order to determine whether metabolic 
acidosis could induce NRF2 activity we measured a panel of its target transcripts. Accordingly, the mRNA levels 
Baseline 2 days HCl 7 days HCl
WT
N = 12
Nrf2 KO
N = 12
WT
N = 6
Nrf2 KO
N = 6
WT
N = 6
Nrf2 KO
N = 6
Weight (g) 25.1 ± 1.9 23.0 ± 0.6* 26.0 ± 1.1 24.6 ± 0.7* 24.2 ± 0.9# 22.7 ± 1.1#
Food intake (g/24 h/body weight) 0.30 ± 0.06 0.40 ± 0.06 * 0.32 ± 0.05 0.34 ± 0.04 0.29 ± 0.01 0.30 ± 0.03#
Water intake (ml/24 h) 2.2 ± 1.1 1.5 ± 0.7* 2.5 ± 1.7 2.1 ± 0.9 4.8 ± 2.6# 5.5 ± 2.6#
Urine
Volume (ml/24 h) 2.4 ± 0.5 1.8 ± 0.5* 2.3 ± 0.7 2.5 ± 0.3# 2.1 ± 0.8 2.8 ± 0.9#
Creatinine excretion (µmol/24 h) 6.4 ± 0.7 5.7 ± 1.2 6.3 ± 1.2 6.8 ± 0.9 4.6 ± 1.9 6.5 ± 1.0
Urinary pH 6.3 ± 0.2 5.9 ± 0.3* 5.6 ± 0.1 5.4 ± 0.1 5.6 ± 0.5 5.3 ± 0.1
NH4/Crea (mEq/mmol) 11.8 ± 12.3(6) 22.9 ± 16.2*(6) 71.5 ± 7.4# 78.7 ± 13.8# 140.2 ± 14.5# 133.7 ± 23.9#
TA/Crea (mEq/mmol) 14.9 ± 2.8(6) 22.4 ± 4.7*(6) ND ND 9.0 ± 5.1# 14.0 ± 0.8*#
NAE/Crea (mEq/mmol) 26.5 ± 9.9(6) 50.1 ± 14.8*(6) ND ND 149.1 ± 10.7 147.7 ± 23.7
Pi/Crea (mEq/mmol) 7.5 ± 0.6 8.8 ± 1.0* 22.7 ± 4.2# 24.2 ± 3.6# 2.3 ± 0.6# 3.4 ± 0.5*#
Ca2+/Crea (mEq/mmol) 0.19 ± 0.4 0.29 ± 0.08* ND ND 3.4 ± 1.0# 3.8 ± 1.2#
Na+/Crea (mEq/mmol) 25.9 ± 2.7 27.7 ± 6.3 ND ND 35.5 ± 3.5# 41.0 ± 3.8*#
Cl−/Crea (mEq/mmol) 48.8 ± 7.0 50.4 ± 10.0 ND ND 213.7 ± 15.7# 209.2 ± 25.4#
K+/Crea (mEq/mmol) 69.7 ± 9.4 70.2 ± 10.0 ND ND 78.6 ± 6.2 77.1 ± 7.2
Table 2. Weight, food intake and urinary values in C57Bl6 and Nrf2 KO mice under normal diet and a 2 or 
7 days HCl load Summary of urinary data obtained from WT and Nrf2 KO mice fed a normal diet (control) 
or a HCl-containing standard diet for 2 and 7 days (acid). Data represent mean ± S.D. of n = 6 animals per 
group. Statistical analysis was performed with a one-way analysis of variance (with Tukey’s post test); *P ≤ 0.05; 
**P ≤ 0.01; ***P ≤ 0.001 for differences between genotypes for the same treatment and #P ≤ 0.05; ##P ≤ 0.01; 
###P ≤ 0.001 for differences between untreated and treated mice for the same genotype.
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of Nqo1, Glutathione S-Transferase Mu 1 (Gstm1), Glutathione S-Transferase Alpha 3 (Gsta3), Cytochrome P450 
Family 2 Subfamily A Member 5 (Cyp2a5), Dihydropyrimidinase (Dpys), Glutamate-Cysteine Ligase Modifier 
Subunit (Gclm), and Gclc were significantly upregulated upon metabolic acidosis and glutathione (GSH) levels 
were maintained at levels similar to those in WT animals on a normal diet (Figs 5a–e and 6a–c). Nrf2 mRNA 
levels remained unchanged suggesting that regulation of NRF2 activity by metabolic acidosis occurs on a post-
transcriptional level (Fig. 5f). In agreement with our previous study, we found a significant down regulation of 
the Nrf2 target genes Nqo1, Gstm1, Gsta3, Cyp2a5, Dpys, Gclm, and Gclc in Nrf2 KO kidneys (Figs 5a–e and 6a,b) 
and a subsequent reduction in the stimulation of their mRNA expression during metabolic acidosis22. Also, GSH 
levels were low in Nrf2 KO kidneys at baseline and remained almost unmeasurable during metabolic acidosis 
(Fig. 6c). The absence of induction of transcripts involved in the defense against oxidative stress during metabolic 
acidosis and the very low levels of GSH in Nrf2 KO kidneys were associated with a significant increase in the levels 
of the proximal tubule specific kidney injury and oxidative stress markers Kim1 (Havcr1) and carbonic anhydrase 
III(Car3), respectively (Fig. 6d,e)23,24.
Discussion
In this study, we have shown for the first time that Nrf2 regulates the induction of the renal glutamine transporter 
SNAT3 (Slc38a3) upon metabolic acidosis. Further, we confirmed our previous observation that NRF2 also con-
trols basal SNAT3 expression in mouse kidney22. Importantly, we found that NRF2 does not control basal Snat3 
mRNA expression in the liver and brain, and identified that both organs are insensitive to Snat3 induction upon 
metabolic acidosis, suggesting a kidney-specific mechanism of control.
With respect to the current knowledge of the transcriptional regulation of Snat3, work by Balkrishna et al. 
demonstrated that tissue-specific Snat3 expression is predominantly controlled by various epigenetic factors25. 
Importantly, they also identified two SP1 binding sites, one important for basal Snat3 promoter transactivation 
and a second pH sensitive SP1 binding site to upregulate Snat3 under metabolic acidosis25. Our data now indi-
cate that NRF2 is also critical for the transcriptional control of Snat3 in mouse kidney. Evidence is increasing 
that NRF2 forms complexes with the transcription factor SP1, which directly affect the regulation of SP1 and 
NRF2 target genes26,27. Furthermore, it has been reported that NRF2 and the SP family proteins, including SP1, 
Figure 2. Ammoniagenic and gluconeogenic enzymes induced by metabolic acidosis are not changed by Nrf2 
deficiency. WT and Nrf2 KO mice were fed a normal diet or a HCl-containing standard diet for 7 days. (a) qPCR 
analysis of Gls in the kidney. (b) Immunoblot detection of GLS using 40 µg total kidney homogenate. (c). qPCR 
analysis of Pepck mRNA expression in the kidney (d). Immunoblot detection of PEPCK using 40 µg total kidney 
homogenate. mRNA values were normalized to Ppia and β-TUBULIN was used as a house-keeping control in 
immunoblots. Data represent mean ± S.D. of n = 6 animals per group. Statistical analysis was performed with 
a one-way analysis of variance (with Tukey’s post test) for mRNA data and Student’s t-test comparing Nrf2 KO 
and WT for protein data; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001.
www.nature.com/scientificreports/
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synergistically enhance the expression of the ion transporters, colonic H/K-ATPase and kNBC1, as shown in 
transfected HEK-293T and CV-1 kidney cells under potassium-depleted conditions28. This effect was abolished 
upon transfection with dominant negative NRF228. Importantly, chromatin immunoprecipitation showed that 
NRF2 and SP1 bound to the promoter of kNBC1, yet only SP1 bound to the promoter of colonic H/K-ATPase, 
suggesting the formation of a NRF2-SP1 complex in certain situations28. The hypothesis that Snat3 transcription 
may be regulated by a NRF2-SP1 complex warrants further investigation.
The SLC38 family of amino acid transporters, to which SNAT3 (SLC38A3) belongs, is split into two major 
subgroups: system A and system N14. SNAT3 belongs to the system N transporters together with SNAT5 and the 
more recently characterized SNAT729. Each transporter has specific activities for the amino acids glutamine, his-
tidine and asparagine. During metabolic acidosis, both glutamine and histidine levels in blood were increased in 
Nrf2 KO mice as compared to WT mice, whereas in kidney tissue of Nrf2 KO mice glutamine remained the same 
and histidine levels were significantly reduced. The changes in plasma might be a direct effect of reduced SNAT3 
expression but suggest that glutamine levels in the kidney are maintained at normal levels by other mechanisms in 
the absence of SNAT3. We observed no difference in the mRNA levels of the N-type transporters Snat5 and Snat7 
in the kidneys of Nrf2 KO mice, therefore it is unlikely that these transporters are involved in a compensatory 
mechanism. The characterized system A transporters; SNAT1, SNAT2 and SNAT4 can carry glutamine but prefer 
small neutral amino acids14. Interestingly, our data show that Snat1 mRNA is significantly upregulated in Nrf2 
KO mice upon metabolic acidosis, whilst in the whole animal Snat3 KO mouse, SNAT1 protein was profoundly 
elevated in the brain7. Although the fold induction of Snat1 was modest, it may contribute to elevating kidney glu-
tamine levels during metabolic acidosis when SNAT3 is lost. The exact localization of SNAT1 in kidney, however, 
Figure 3. Snat/Slc38 transporter family members in the kidney may compensate for the loss of Snat3 in 
Nrf2 KO kidney. WT and Nrf2 KO mice were fed a normal diet or a HCl-containing standard diet for 7 days. 
(a–d) qPCR analysis of Snat1, 2, 4 and 7 in kidney. mRNA values were normalized to Ppia. Data represent 
mean ± S.D. of n = 6 animals per group. Statistical analysis was performed with a one-way analysis of variance 
(with Tukey’s post test); *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001.
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Figure 4. Amino acid transporter levels in the kidney remain unchanged in Nrf2 KO kidney upon metabolic 
acidosis. WT and Nrf2 KO mice were fed a normal diet or a HCl-containing standard diet for 7 days. qPCR and 
immunoblotting of (a,b) 4f2hc, (c,d) Lat2, (e,f) Tat1, and (g,h) B°at1 in the kidney. Immunoblot detection for 
4F2hc, LAT2 and TAT1 were performed with 20 µg total kidney membrane preparation and for B°AT1 with 
15 µg brush border membrane preparation. mRNA values were normalized to Ppia. β-TUBULIN was used as a 
house-keeping control for the immunoblots. Data represent mean ± S.D. of n = 6 animals per group. Statistical 
analysis was performed with a one-way analysis of variance (with Tukey’s post test); *P ≤ 0.05; ***P ≤ 0.001. 
Statistical analysis for immunoblotting was performed with Student’s t-test; a = 0.05.
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is currently unknown. We also observed a significant induction of the sodium/proton exchanger Nhe4 (Slc9a4) 
in the Nrf2 KO mouse kidney following metabolic acidosis. NHE4 is critical for ammonia transport in the thick 
ascending limb of the loop of Henle, interstitial ammonia accumulation, and maintenance of systemic pH30. Its 
upregulation in Nrf2 KO mice may serve compensatory functions.
Metabolic acidosis results in the upregulation of enzymes which direct the metabolism of glutamine towards 
ammoniagensis (GLS and glutamate dehydrogenase 1) and gluconeogenesis (PEPCK). When working efficiently, 
both pathways combine to produce two NH3 and two HCO3− ions per glutamine molecule5. NRF2 has also 
been shown to influence the direction of the metabolism of glutamine in favor of GSH biosynthesis and the 
TCA cycle21. In addition, NRF2 can inhibit gluconeogenesis, although the mechanism remains to be fully under-
stood19. We show that GSH levels are significantly reduced in the Nrf2 KO kidney compared to WT, probably 
due to the downregulation of GCLC and GCLM, which code for the two subunits of the rate limiting enzyme in 
glutathione synthesis, GCL21. We show that the mRNA levels of Gclc and Gclm are significantly induced and that 
GSH levels are maintained upon metabolic acidosis in WT kidney, which suggests that glutamine is being utilized 
for all the pathways mentioned above during metabolic acidosis. This would imply that an active NRF2 system 
regulates pathways that compete for glutamine in the kidney and therefore reduces the efficiency by which the 
proximal tubular cells can utilize glutamine for ammoniagenesis and gluconeogenesis. Therefore, it is possible 
that in the absence of NRF2 in this setting, the demand for glutamine is reduced since it is no longer fluxed into 
GSH biosynthesis. If this is the case, in the absence of SNAT3, intracellular demands for glutamine may be met 
by the induction of the SNAT1 transporter or additional mechanisms yet to be identified. This hypothesis has to 
be tested in future experiments.
The primary role of NRF2 is to coordinate the upregulation of antioxidant and detoxification genes to defend 
against the detrimental effects of oxidative stress31. The importance of this pathway, with respect to the kidney 
have been demonstrated to protect against a number of nephrotoxic insults in Nrf2 KO animals32. Importantly, 
animal models of chronic kidney disease (CKD) showed reduced levels of NRF2 and its target genes33–36. 
Although this current investigation focused on SNAT3 and metabolic acidosis, it also gave us the opportunity to 
examine what happens to the NRF2 system in the kidney during metabolic acidosis. We show for the first time in 
vivo that the NRF2 target genes Gclm, Gclc, Nqo1, Gstm1, Gsta3, Cyp3a5 and Dyps are significantly induced upon 
metabolic acidosis and that Nrf2 is needed to maintain GSH levels in the WT kidney under such conditions22. 
Thus, our data suggest that metabolic acidosis in this setting is an oxidative insult and that the kidneys baseline 
defense needs to be stimulated in a NRF2-dependent manner in order to deal with the perturbation in homeo-
stasis. Indeed there is in vitro evidence that NRF2 is activated in the prostate cancer cell AT-1 following exposure 
Figure 5. NRF2 activity is induced upon metabolic acidosis. WT and Nrf2 KO mice were fed a normal diet or a 
HCl-containing standard diet for 7 days. (a–f) qPCR analysis of Nrf2 target genes Nqo1, Gstm1, Gsta3, Cyp2a5, 
Dyps and Nrf2 in the kidney. mRNA values were normalized to Ppia. Data represent mean ± S.D. of n = 6 
animals per group. Statistical analysis was performed with a one-way analysis of variance (with Tukey’s post-
test); *P ≤ 0.05; ***P ≤ 0.001; ****P ≤ 0.0001.
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to acidic media; however, the opposite was observed in the MCF-7 breast cancer cell line37,38. Additionally, in the 
Nrf2 KO kidney mRNA levels of Gclm, Gclc, Nqo1, Gstm1, Gsta3, Cyp2a5 and Dyps were significantly depleted, 
as well as total GSH, in agreement with our previous study22. Importantly, upon metabolic acidosis we observed 
a significant increase in the proximal tubular injury and oxidative stress markers Kim124 and carbonic anhydrase 
type 3 (Car3)23 specifically in the Nrf2 KO kidneys. Although the kidney does not have any major acid handling 
defects in this experimental setting after 7 days, this is an indicator that the loss of Nrf2 may be detrimental to the 
function of the proximal tubule following long term exposure and should be investigated further. The data may 
also indicate that the role of SNAT3 in ammoniagenesis is less critical than suggested by previous data and that 
SNAT3 may rather contribute to the anti-oxidative defense by supplying substrates for GSH synthesis. Clearly, 
this will require further detailed analyses developing cell-specific Snat3 deficient mouse models.
In summary, NRF2 regulates the levels of SNAT3 in response to metabolic acidosis. However, in the absence of 
SNAT3 induction, the kidney does not show any impairment in the ability to adapt acid-excretion to an acid-load. 
Compensatory adaption of other transporters in the kidney or metabolic redirection of glutamine away from glu-
tathione synthesis may account for the loss of SNAT3 induction but this is associated with increased vulnerability 
to oxidative stress.
Methods and Materials
Animals. Male Nrf2 KO mice, age 10–14 weeks old (C57BL/6 background, generation, and genotyping have 
been described previously39,40), were bred at the University of Liverpool Biomedical Services Unit and trans-
ferred to the Institute of Physiology, University of Zürich. Age and sex matched WT C57BL/6 mice were supplied 
by Janvier, France. All animal experiments were performed according to the Swiss Law of Animal Welfare and 
approved by the local authority (Veterinäramt Zurich).
For experiments, mice were housed in metabolic cages (Techniplast, Buguggiate, Italy). Mice were given water 
ad libitum and were fed with a standard powdered laboratory chow mixed with water (50/75 w/v) (Kliba, Augst, 
Switzerland) to adapt to metabolic cages for 2 days. Two sets of experiments were performed. The first set of 6 WT 
Figure 6. Metabolic acidosis increases oxidative stress in Nrf2 KO kidney. WT and Nrf2 KO mice were fed 
a normal diet or a HCl-containing standard diet for 7 days. qPCR analysis of the rate limiting glutathione 
synthesis enzyme, GSL, subunits (a) Gclc and (b) Gclm. (c) total glutathione contents of kidney tissue, 
normalized to tissue weight. qPCR analysis of kidney proximal tubule oxidative stress markers (d), Kim1 and 
(e), Car3. mRNA values were normalized to Ppia. Data represent mean ± S.D. of n = 6 animals per group. 
Statistical analysis was performed with a one-way analysis of variance (with Tukey’s post test); *P ≤ 0.05; 
**P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001.
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and 6 Nrf2 KO mice received a standard diet for 2 days, during which 24 h urine samples were collected under 
light mineral oil in the urine collector to determine daily urinary parameters. After 2 days, before euthanasia, 
retro-orbital blood samples were taken under light anesthesia with isoflurane. Plasma, kidneys, brains and livers 
were harvested after euthanasia. The second set of 6 WT and 6 Nrf2 KO mice received a standard diet during 
the first 24 h urine collection and were then switched to a dietary acid load for 7 days where mice were given a 
HCl-containing diet with 150 ml of 0.33 M HCl added to 100 g powdered standard food. Food, water intake, and 
urine excretion were monitored at day 0, 2 and 7 of the HCl diet. On the last day of experiments, before eutha-
nasia, retro-orbital blood samples were taken under light anesthesia with isoflurane. Plasma, kidneys, brains and 
livers were harvested after euthanasia.
Analytic procedures. Blood pH, pCO2, and electrolytes were measured with a pH/blood-gas analyzer 
(ABL77 Radiometer). Urinary pH was measured with a pH-meter (Metrohm AG, Canada) and creatinine by 
a modified kinetic Jaffé colorimetric method41. Urinary NH4+ was measured with the Berthelot protocol42. 
Urinary inorganic phosphate (Pi) concentration was determined by the phosphomolybdate method43. Urinary 
titratable acidity was measured according to Jorgensen and Siggaard-Andersen44,45. Briefly, CO2 was eliminated 
by hydrochloric acid addition. Then, titratable acidity was measured by sodium hydroxide (1 N) titration to 
pH 7.40 using DL 55 Mettler Toledo® titrator, ST20 Mettler® sample changer and Inlab® Semi micro pH elec-
trode. Urinary pH was measured on fresh urine with a pH-meter. Citric acid was measured using a kit from 
Boehringer Mannheim/ R-Biopharm.
Amino acid measurements. Quantitative amino acid measurements were performed using targeted 
LC-MS/MS based on the method described by Harder et al.46. Briefly, plasma samples (10 µl) were dissolved in 
500 µl ice-cold methanol containing an internal standard mixture of 15 deuterated amino acids. After centrifuga-
tion (10 min, 10 °C, x g), samples were dried. Kidney tissue samples were extracted in 30x methanol mass using 
TissueLyser. Amino acids in plasma and kidney samples were derivatized to their butyl esters as described by 
Gucciardi et al.47. Briefly, a mixture of 95% n-butanol and 5% acetylchloride (v/v) was added to the dried samples. 
Subsequently, the samples were incubated at 60 °C for 15 minutes at 600 rpm (Eppendorf Thermomixer Comfort; 
Eppendorf, Hamburg, Germany). The samples were dried and reconstituted in a 200 µl mixture of methanol/
water/formic acid (70/30/0.1% v/v).
The analysis was performed on a triple quadrupole QTRAP 5500 LC-MS/MS system operating in positive 
ESI mode (AB Sciex, Framingham, MA) equipped with a 1200 series binary pump (Agilent, Santa Clara, CA) 
and coupled to an HTC pal autosampler (CTC Analytics, Zwingen, Switzerland). Chromatographic separation 
was achieved using a Zorbax Eclipse XDB-C18 column (length 150 mm, internal diameter 3.0 mm, particle size 
3.5 µm; Agilent). Analytes were measured in scheduled multiple reaction monitoring (MRM). For absolute quan-
tification, a 10-point calibration was performed, using a mixture containing all amino acids in the measurement 
(A9906 amino acid standards, Sigma-Aldrich, Taufkirchen, Germany). Data analysis was done using Analyst 
1.5.1® software (AB Sciex).
Analysis of mRNA expression. For isolation of total RNA kidney tissue (n = 6 per group), the Direct-Zol 
RNA MiniPrep kit (Zymo Research, Freiburg, Germany) including on-column DNAse treatment was applied. 
RNA concentration was assessed using a NanoDrop ND 1000 (Fisher Scientific, Reinach, Switzerland). cDNA 
was synthesized from 2 μg total RNA using Superscript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA) 
following the manufacturers protocol. Relative mRNA quantification was performed by real-time quantitative 
RT-PCR using a rotor-gene 6000 (Corbett Research, Sydney, Australia). Briefly, the cDNA (10 ng) was mixed with 
gene-specific primers (Microsynth, Balgach, Switzerland) (200 nM) (supplementary Table S4) and KAPA SYBR 
FAST qPCR reagent (Kapasystems, Boston, MA, USA) (5 μl), in a final volume of 10 μl. Thermal cycler parameters 
were as follows: 15 min at 95 °C, followed by amplification of cDNA for 40 cycles with melting for 15 s at 94 °C, 
annealing for 30 s at 56 °C and extension for 30 s at 72 °C. For each sample, three technical replicates were ana-
lyzed. Expression was normalized to cyclophylin A (Ppia) control. Fold changes were quantified as 2−(ΔCt sample-ΔCt 
control), as described previously48.
Immunoblotting. Total kidney homogenates were prepared by mechanical dispersion (Polytron 
Kinematica PT10/36, Switzerland) in 200 μl ice-cold resuspension buffer (200 mM Mannitol, 80 mM HEPES, 
41 mM KOH, pH 7.5) containing EDTA-free proteinase inhibitor mix (Roche, Mannheim, Germany). The total 
membrane fraction was isolated from total homogenates by first centrifuging it at 2000 rpm (5415 R Centrifuge, 
Eppendorf, Hamburg, Germany) for 20 min at 4 °C. Next the supernatant was further centrifuged at 41000 rpm 
(Sorvall RC M120 EX Centrifuge, RP45A-0030 rotor) at 4 °C for 1 hour and the pellet was resuspended in resus-
pension buffer7.
Brush border membrane vesicles were prepared as described previously49. Briefly, mouse kidneys were 
homogenized in 2 ml of homogenization solution (300 mM Mannitol, 5 mM EGTA, 12 mM Tris, pH 7.1 con-
taining EDTA-free proteinase inhibitor mix) followed by addition of 2.8 ml ice-cold distilled water and 58 μl 
of 1 M MgCl2. The mixture was kept for 15 min on ice and centrifuged at 4600 rpm for 15 min at 4 °C (5415 R 
Centrifuge). The supernatant was centrifuged at 16000 rpm for 30 min at 4 °C (Sorvall RC 5 C Plus centrifuge, 
SS34 rotor) and the pellet was resuspended in 2 ml membrane buffer (300 mM Mannitol, 20 mM HEPES, 12 mM 
Tris, pH 7.4, containing EDTA-free proteinase inhibitor mix). The mixture was centrifuged again at 16000 rpm 
for 30 min at 4 °C and the pellet resuspended in 200 µl membrane buffer.
Whole PCT cell lysates were obtained by lysing cells in 100 µl of ice cold RIPA buffer (Sigma, St. Louis, MO) 
supplemented with 1x complete mini protease inhibitors (Roche, Mannheim, Germany).
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The total protein concentration was measured with the Bio-Rad DC Protein Assay (Bio-Rad, USA) and 
10–40 µg of protein preparations diluted in Laemmli buffer were loaded onto SDS-PAGE electrophoresis gels 
with 8–10% polyacrylamide, followed by transfer onto polyvinylidene difluoride membranes (Immobilon-FL, 
Millipore, USA). Immunoblotting was performed by first blocking with 5% non-fat dry milk in TBS-Tween fol-
lowed by 30 min washing and overnight incubation with primary antibodies. After additional washing steps, 
anti-mouse, anti-rabbit or anti-goat IgG horseradish peroxidase-conjugated antibodies at 1:5000 or 1:10000 dilu-
tions were used and the chemiluminescent signal was generated using the HRP substrate Immobilon Western 
(Millipore, Billerica, MA, USA). Images were acquired with the Imagequant LAS-4000 (Fujifilm). We used as 
primary antibodies: rabbit anti-SNAT3 (1:1000)50, goat anti-SNAT3 (1:1000, sc-33445, Santa Cruz Biotechnology, 
Santa Cruz, CA, USA), rabbit anti-PEPCK (1:5000, Cayman Chemical, Ann Arbor, MI, USA), rabbit anti-GLS/
PDG (1:5000, kindly provided by N. Curthoys, Colorado State University, USA), rabbit anti-TAT1 (1:500)51, 
mouse anti-4F2hc (1:1000)(Santa Cruz Biotechnology, Santa Cruz, CA, USA).), rabbit anti-B0AT1 (1:1000)52, 
rabbit anti-b0,+AT1 (1:1:2000)53, rabbit anti-rBAT (1:2000)54, kindly provided by Manuel Palacín, Universitat 
de Barcelona, Spain), and rabbit LAT2 (1:2000)55. Measured densitometric values for all proteins were corrected 
by mouse anti-β-TUBULIN (1:25000, Sigma, USA) densitometric values for samples from the in vivo study and 
anti-β-ACTIN (1:10000, Santa Cruz Biotechnology) densitometric values for samples from PCT experiments. If 
necessary, membranes were subjected to mild acid stripping in 0.2 M glycine, 0.1% SDS, 1% Tween 20, pH 2.2 
twice for 5–10 minutes and washed twice with PBS and TBST before blocking and reprobing.
Isolation of proximal tubular cells. Primary proximal tubular cells (PCT) were isolated from male C57/
BL6 mice (7 to 14 weeks) as described previously56. Briefly, renal cortices were sliced in dissection solution (HBSS 
with 15 mM HEPES, 10 mM D-glucose, 5 mM glycine, 1 mM L-alanine buffered to pH 7.4 and osmolality of 325 
mosmol/kgH2O) into pieces of approximately 1 mm2 followed by collagenase type II digestion (Worthington 
Biochemical, Lakewood, NJ) for 30 min at 37 °C in presence of soybean trypsin inhibitor (Sigma, St. Louis, 
MO). Then they were transferred onto a sieve tower with two pore sizes (250 µm and 80 µm) (Retsch, Haan, 
Germany). The proximal tubule fragments on the lower sieve were collected by flushing the sieve in the reverse 
direction with dissection solution containing 1% BSA. Upon centrifugation the fragments of two kidneys were 
resuspended in culture medium (1:1 DMEM/F12 without phenol red and supplemented with 15 mM HEPES, 
0.55 mM Na-pyruvate, 100 × non-essential amino acids 10 ml/L, and REGM SingleQuot Kit Supplements & 
Growth Factors (Lonza, Verviers, Belgium) and distributed onto one 24 well plate and left unstirred for 72 h at 
37 °C and 95% air-5% CO2 in a standard humidified incubator. After 3 days the medium was replaced and on day 
7 the cells reached confluence and were used for further experiments.
RNA interference. Short interfering RNA (siRNA) targeting mouse Nrf2 (D-040766-01) and scrambled 
non targeting control (D-001810-03) were purchased from the Dharmacon siGENOME library (Dharmacon via 
Fisher Scientific, Reinach, Switzerland). Confluent isolated proximal tubules were transfected with 20 nM siRNA 
using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol. After 
incubation for 24 h, cells were exposed to media of adjusted to pH 7.4 or 6.5 for a further 24 h.
Quantification of Glutathione. Kidney tissue (15–20 mg) was homogenized and total glutathione lev-
els were determined using the GSH-Glo assay kit (Promega, Southampton, UK) following the manufacturer’s 
instructions.
Statistics. Data are expressed as mean ± S.D. of 6 animals per group or 4 independent PCT isolations. The 
significance of differences within the data were assessed by one-way analysis of variance (with Tukey’s post-test) 
or Student’s t-test. Amino acids profiles in kidney and plasma were analyzed using the Mann-Whitney test as we 
cannot assume the assumption of normality in these datasets. A two-sided p value of ≤0.05 was considered to be 
statistically significant. Figures were generated using GraphPad Prism 6.
Data Availability. All data generated or analyzed during this study are included in this published article (and 
its Supplementary Information files).
References
 1. Alpern, R. J., Herbert, S. C., Seldin, D. W. & Giebisch, G. H. Seldin and Giebisch’s The kidney: physiology and pathophysiology. 4th edn, 
(Elsevier/Academic Press, 2008).
 2. Hamm, L. L. & Simon, E. E. Roles and mechanisms of urinary buffer excretion. Am J Physiol 253, F595–605 (1987).
 3. Wagner, C. A., Devuyst, O., Belge, H., Bourgeois, S. & Houillier, P. The rhesus protein RhCG: a new perspective in ammonium 
transport and distal urinary acidification. Kidney Int 79, 154–161, https://doi.org/10.1038/ki.2010.386 (2011).
 4. Wagner, C. A., Devuyst, O., Bourgeois, S. & Mohebbi, N. Regulated acid-base transport in the collecting duct. Pflugers Arch 458, 
137–156, https://doi.org/10.1007/s00424-009-0657-z (2009).
 5. Curthoys, N. P. & Moe, O. W. Proximal tubule function and response to acidosis. Clin J Am Soc Nephrol: CJASN 9, 1627–1638, 
https://doi.org/10.2215/CJN.10391012 (2014).
 6. Welbourne, T. C., Childress, D. & Givens, G. Renal regulation of interorgan glutamine flow in metabolic acidosis. Am J Physiol 251, 
R859–866 (1986).
 7. Chan, K. et al. Loss of function mutation of the Slc38a3 glutamine transporter reveals its critical role for amino acid metabolism in 
the liver, brain, and kidney. Pflugers Arch 468, 213–227, https://doi.org/10.1007/s00424-015-1742-0 (2016).
 8. Burki, R. et al. Impaired expression of key molecules of ammoniagenesis underlies renal acidosis in a rat model of chronic kidney 
disease. Nephrol Dial Transplant 30, 770–781, https://doi.org/10.1093/ndt/gfu384 (2015).
 9. Busque, S. M. & Wagner, C. A. Potassium restriction, high protein intake, and metabolic acidosis increase expression of the 
glutamine transporter SNAT3 (Slc38a3) in mouse kidney. Am J Physiol Renal Physiol 297, F440–450, https://doi.org/10.1152/
ajprenal.90318.2008 (2009).
www.nature.com/scientificreports/
1 2SCIeNTIfIC RepoRts |  (2018) 8:5629  | DOI:10.1038/s41598-018-24000-2
 10. Busque, S. M., Stange, G. & Wagner, C. A. Dysregulation of the glutamine transporter Slc38a3 (SNAT3) and ammoniagenic enzymes 
in obese, glucose-intolerant mice. Cell Physiol Biochem 34, 575–589, https://doi.org/10.1159/000363024 (2014).
 11. Nowik, M. et al. Genome-wide gene expression profiling reveals renal genes regulated during metabolic acidosis. Physiol Genomics 
32, 322–334, https://doi.org/10.1152/physiolgenomics.00160.2007 (2008).
 12. Moret, C. et al. Regulation of renal amino acid transporters during metabolic acidosis. Am J Physiol Renal Physiol 292, F555–566, 
https://doi.org/10.1152/ajprenal.00113.2006 (2007).
 13. Solbu, T. T. et al. Induction and targeting of the glutamine transporter SN1 to the basolateral membranes of cortical kidney tubule 
cells during chronic metabolic acidosis suggest a role in pH regulation. J Am Soc Nephrol 16, 869–877, https://doi.org/10.1681/
ASN.2004060433 (2005).
 14. Rubio-Aliaga, I. & Wagner, C. A. Regulation and function of the SLC38A3/SNAT3 glutamine transporter. Channels 10, 440–452, 
https://doi.org/10.1080/19336950.2016.1207024 (2016).
 15. Kobayashi, M. & Yamamoto, M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen 
species. Advances in enzyme regulation 46, 113–140, https://doi.org/10.1016/j.advenzreg.2006.01.007 (2006).
 16. Copple, I. M., Goldring, C. E., Kitteringham, N. R. & Park, B. K. The keap1-nrf2 cellular defense pathway: mechanisms of regulation 
and role in protection against drug-induced toxicity. Handbook of experimental pharmacology, 233–266, https://doi.org/10.1007/978-
3-642-00663-0_9 (2010).
 17. McMahon, M., Thomas, N., Itoh, K., Yamamoto, M. & Hayes, J. D. Dimerization of substrate adaptors can facilitate cullin-mediated 
ubiquitylation of proteins by a “tethering” mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J Biol Chem 281, 
24756–24768, https://doi.org/10.1074/jbc.M601119200 (2006).
 18. Tong, K. I., Kobayashi, A., Katsuoka, F. & Yamamoto, M. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge 
and latch mechanism. Biol Chem 387, 1311–1320, https://doi.org/10.1515/BC.2006.164 (2006).
 19. Hayes, J. D. & Dinkova-Kostova, A. T. The Nrf2 regulatory network provides an interface between redox and intermediary 
metabolism. Trends Biochem Sci 39, 199–218, https://doi.org/10.1016/j.tibs.2014.02.002 (2014).
 20. Kitteringham, N. R. et al. Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as 
primary Nrf2-dependent pathways in the liver. J Proteomics 73, 1612–1631, https://doi.org/10.1016/j.jprot.2010.03.018 (2010).
 21. Mitsuishi, Y. et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer cell 22, 66–79, 
https://doi.org/10.1016/j.ccr.2012.05.016 (2012).
 22. Shelton, L. M. et al. Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidney. Kidney Int 88, 
1261–1273, https://doi.org/10.1038/ki.2015.286 (2015).
 23. Gailly, P. et al. A novel renal carbonic anhydrase type III plays a role in proximal tubule dysfunction. Kidney Int 74, 52–61, https://
doi.org/10.1038/sj.ki.5002794 (2008).
 24. Vaidya, V. S. et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker 
qualification studies. Nat Biotechnol 28, 478–485, https://doi.org/10.1038/nbt.1623 (2010).
 25. Balkrishna, S., Broer, A., Welford, S. M., Hatzoglou, M. & Broer, S. Expression of glutamine transporter Slc38a3 (SNAT3) during 
acidosis is mediated by a different mechanism than tissue-specific expression. Cell Physiol Biochem 33, 1591–1606, https://doi.
org/10.1159/000358722 (2014).
 26. Chi, P. L., Lin, C. C., Chen, Y. W., Hsiao, L. D. & Yang, C. M. CO Induces Nrf2-Dependent Heme Oxygenase-1 Transcription by 
Cooperating with Sp1 and c-Jun in Rat Brain Astrocytes. Molecular neurobiology 52, 277–292, https://doi.org/10.1007/s12035-014-
8869-4 (2015).
 27. Gao, P. et al. Nrf2 ameliorates diabetic nephropathy progression by transcriptional repression of TGFbeta1 through interactions with 
c-Jun and SP1. Biochim Biophys Acta 1839, 1110–1120, https://doi.org/10.1016/j.bbagrm.2014.06.018 (2014).
 28. Lee, C. B., Lee, Y. S., Lee, J. Y., Lee, S. E. & Ahn, K. Y. Nrf2 and Sp family synergistically enhance the expression of ion transporters 
in potassium-depleted conditions. J Nephrol 25, 225–232, https://doi.org/10.5301/JN.2011.8448 (2012).
 29. Hagglund, M. G. et al. Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons. J Biol Chem 286, 
20500–20511, https://doi.org/10.1074/jbc.M110.162404 (2011).
 30. Bourgeois, S. et al. NHE4 is critical for the renal handling of ammonia in rodents. J Clin Invest 120, 1895–1904, https://doi.
org/10.1172/JCI36581 (2010).
 31. Bryan, H. K., Olayanju, A., Goldring, C. E. & Park, B. K. The Nrf2 cell defence pathway: Keap1-dependent and -independent 
mechanisms of regulation. Biochem Pharmacol 85, 705–717, https://doi.org/10.1016/j.bcp.2012.11.016 (2013).
 32. Shelton, L. M., Park, B. K. & Copple, I. M. Role of Nrf2 in protection against acute kidney injury. Kidney Int 84, 1090–1095, https://
doi.org/10.1038/ki.2013.248 (2013).
 33. Ruiz, S., Pergola, P. E., Zager, R. A. & Vaziri, N. D. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and 
inflammation in chronic kidney disease. Kidney Int 83, 1029–1041, https://doi.org/10.1038/ki.2012.439 (2013).
 34. Kim, H. J., Sato, T., Rodriguez-Iturbe, B. & Vaziri, N. D. Role of intrarenal angiotensin system activation, oxidative stress, 
inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis. J 
Pharm Exp Ther 337, 583–590, https://doi.org/10.1124/jpet.110.175828 (2011).
 35. Kim, H. J. & Vaziri, N. D. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal 
failure. Am J Physiol Renal Physiol 298, F662–671, https://doi.org/10.1152/ajprenal.00421.2009 (2010).
 36. Aminzadeh, M. A., Nicholas, S. B., Norris, K. C. & Vaziri, N. D. Role of impaired Nrf2 activation in the pathogenesis of oxidative 
stress and inflammation in chronic tubulo-interstitial nephropathy. Nephrol Dial Transplant 28, 2038–2045, https://doi.org/10.1093/
ndt/gft022 (2013).
 37. Ihling, A., Ihling, C. H., Sinz, A. & Gekle, M. Acidosis-Induced Changes in Proteome Patterns of the Prostate Cancer-Derived 
Tumor Cell Line AT-1. J Proteome Res 14, 3996–4004, https://doi.org/10.1021/acs.jproteome.5b00503 (2015).
 38. Lamonte, G. et al. Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress. Cancer Metab 1, 23, https://
doi.org/10.1186/2049-3002-1-23 (2013).
 39. Itoh, K. et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant 
response elements. Biochem Biophys Res Commun 236, 313–322 (1997).
 40. McMahon, M. et al. The Cap’n’Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both 
constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 61, 3299–3307 
(2001).
 41. Seaton, B. & Ali, A. Simplified manual high performance clinical chemistry methods for developing countries. Med Lab Sci 41, 
327–336 (1984).
 42. Berthelot, M. Violet d’aniline. Rep Chim App 1, 284 (1859).
 43. Fiske, C. & Subbarow, J. The colorometric determination of phosphorus. J Biol Chem 66, 375–400 (1925).
 44. Jorgensen, K. Titrimetric determination of the net excretion of acid/base in urine. Scand J Clin Lab Invest 9, 287–291 (1957).
 45. Siggaard-Andersen, O. Titratable acid or base of body fluids. Ann N Y Acad Sci 133, 41–58 (1966).
 46. Harder, U., Koletzko, B. & Peissner, W. Quantification of 22 plasma amino acids combining derivatization and ion-pair LC-MS/MS. 
J Chromatogr B Analyt Technol Biomed Life Sci 879, 495–504, https://doi.org/10.1016/j.jchromb.2011.01.010 (2011).
 47. Gucciardi, A., Pirillo, P., Di Gangi, I. M., Naturale, M. & Giordano, G. A rapid UPLC-MS/MS method for simultaneous separation 
of 48 acylcarnitines in dried blood spots and plasma useful as a second-tier test for expanded newborn screening. Anal Bioanal 
Chem 404, 741–751, https://doi.org/10.1007/s00216-012-6194-1 (2012).
www.nature.com/scientificreports/
13SCIeNTIfIC RepoRts |  (2018) 8:5629  | DOI:10.1038/s41598-018-24000-2
 48. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta 
C(T)) Method. Methods 25, 402–408, https://doi.org/10.1006/meth.2001.1262 (2001).
 49. Biber, J., Stieger, B., Stange, G. & Murer, H. Isolation of renal proximal tubular brush-border membranes. Nat Protoc 2, 1356–1359, 
https://doi.org/10.1038/nprot.2007.156 (2007).
 50. Rooman, I. et al. Amino acid transporters expression in acinar cells is changed during acute pancreatitis. Pancreatology 13, 475–485, 
https://doi.org/10.1016/j.pan.2013.06.006 (2013).
 51. Ramadan, T. et al. Basolateral aromatic amino acid transporter TAT1 (Slc16a10) functions as an efflux pathway. J Cell Physiol 206, 
771–779, https://doi.org/10.1002/jcp.20531 (2006).
 52. Kleta, R. et al. Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat Genet 36, 999–1002, https://doi.org/10.1038/
ng1405 (2004).
 53. Pfeiffer, R. et al. Luminal heterodimeric amino acid transporter defective in cystinuria. Mol Biol Cell 10, 4135–4147 (1999).
 54. Furriols, M. et al. rBAT, related to L-cysteine transport, is localized to the microvilli of proximal straight tubules, and its expression 
is regulated in kidney by development. J Biol Chem 268, 27060–27068 (1993).
 55. Rossier, G. et al. LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine. J Biol Chem 274, 
34948–34954 (1999).
 56. Terryn, S. et al. A primary culture of mouse proximal tubular cells, established on collagen-coated membranes. Am J Physiol Renal 
Physiol 293, F476–485, https://doi.org/10.1152/ajprenal.00363.2006 (2007).
Acknowledgements
We thank Stéphanie Baron, Hôpital Européen Georges Pompidou, Département de Physiologie, Assistance 
Publique-Hôpitaux de Paris, Paris, France, for measurements of titratable acidity. The use of the ZIRP Core 
Facility for rodent phenotyping is gratefully acknowledged. This work was supported by the Swiss National 
Centre of Competence in Research (NCCR) ‘Kidney.CH’, Switzerland and the Wellcome Trust (grant number 
094128/Z/10/Z). Adam Lister and Pedro H. Imenez Silva were supported by the International Fellowship Kidney 
International Programme on Integrative Kidney Physiology and Pathophysiology of the European Community’s 
seventh Framework Programme (FP7/2007-2013) under grant agreement number 2346539. Pedro H. Imenez 
Silva was also a recipient of Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) grant 
number 205625/2014-2.
Author Contributions
A.L. conceived the experiments, conducted the experiments, analyzed the results, and writing of manuscript. 
S.B. conceived the experiments, conducted the experiments and analyzed the results. P.H.I.S. conceived the 
experiments, conducted the experiments and analyzed the results. I.R.A. planning of experiments and analysis 
and interpretation of data. P.M. conducted the experiments. J.W. conducted the experiments. L.M.S. conducted 
the experiments. B.K. conducted the experiments and analyzed the results. F.V. planning the experiments. O.D. 
planning the experiments. P.G. conducted the experiments. H.D. provided amino acid platform for analysis. 
C.E.G. provided Nrf2 KO mice. I.M.C. provided Nrf2 KO mice. C.A.W. planning of experiments, interpretation 
of data, writing of manuscript. A.O. planning of experiments, interpretation of data, writing of manuscript. All 
authors reviewed the manuscript
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-24000-2.
Competing Interests: The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2018
